Isolated Glenohumeral Corticosteroid Injection Versus Concomitant Capsule Preserving Hydrodilatation
CSvsCSHD
The Efficacy of Single-shot Capsule-preserving Hydrodilatation With Corticosteroids in Treating Adhesive Capsulitis of the Shoulder: A Randomized Controlled Trial Versus Isolated Corticosteroid Injection
1 other identifier
interventional
50
1 country
1
Brief Summary
This clinical trial investigates whether concomitant capsule-preserving hydrodilatation (CSHD) is more effective than isolated glenohumeral corticosteroid injection (CS) in treating shoulder adhesive capsulitis. The main questions it aims to answer are
- Is CSHD inferior to CS in immediate pain relief as the solution is diluted?
- Is CSHD superior to CS in improving the range of motion as the contracted capsule is dilated? Group CS will receive an ultrasound-guided glenohumeral corticosteroid injection only, with a solution of 5 mL. Group CSHD will receive an ultrasound-guided glenohumeral corticosteroid with hydrodilatation, with a solution of 20 mL. Clinical scores and range of motion will be compared between the groups up to six months post-injection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2015
CompletedFirst Submitted
Initial submission to the registry
June 24, 2024
CompletedFirst Posted
Study publicly available on registry
July 10, 2024
CompletedJuly 10, 2024
July 1, 2024
2 years
June 24, 2024
July 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual analog scale (VAS) for pain
Patient-reported 0-10 scale of pain, 0: no pain, 10: very severe pain
Change from the baseline to 6 months
Secondary Outcomes (3)
Range of motion (ROM)
Change from the baseline to 6 months
American Shoulder and Elbow Surgeons (ASES) shoulder score
Change from the baseline to 6 months
Constant-Murley score
Change from the baseline to 6 months
Study Arms (2)
Isolated corticosteroid injection
EXPERIMENTALUltrasound-guided posterior approach of glenohumeral space injection for adhesive capsulitis of the shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine.
Concomitant hydrodilatation with corticosteroid injection
ACTIVE COMPARATORUltrasound-guided posterior approach of glenohumeral space hydrodilatation for adhesive capsulitis of the shoulder. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, and 15 mL normal saline
Interventions
Using a 21-gauge spinal needle, the predefined steroid solution was injected under ultrasound guidance using 5- to 13-MHz linear probe into the glenohumeral space through the posterior approach.
Using a 21-gauge spinal needle, the predefined steroid solution with additional 15 mL of normal saline was injected under ultrasound guidance using 5- to 13-MHz linear probe into the glenohumeral space through the posterior approach.
1mL of Triamcinolone 40mg/1mL solution was included in the injection/hydrodilatation regimen.
4mL of 1% Lidocaine solution was included in the injection/hydrodilatation regimen.
15mL of 1% Lidocaine solution was included in the hydrodilatation regimen.
Eligibility Criteria
You may qualify if:
- Two or more of the following criteria within the shoulder's range of motion:
- Abduction and forward elevation below 100˚
- External rotation at the side below 30˚
- Internal rotation at 90˚ of abduction below 30˚
You may not qualify if:
- History of shoulder surgery, trauma, nerve injury
- Concomitant rotator cuff/biceps lesions in ultrasound or MRI
- Glenohumeral arthritis in simple X-ray
- Calcific tendinosis in simple X-ray
- Underlying conditions: cancer, mental illness, hormonal imbalance
- Diabetes with HbA1c levels exceeding 7.0%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chuncheon Sacred Heart Hospital
Chuncheon, Gangwondo, 700-204, South Korea
Related Publications (6)
Neviaser AS, Hannafin JA. Adhesive capsulitis: a review of current treatment. Am J Sports Med. 2010 Nov;38(11):2346-56. doi: 10.1177/0363546509348048. Epub 2010 Jan 28.
PMID: 20110457RESULTCho CH, Lee YH, Kim DH, Lim YJ, Baek CS, Kim DH. Definition, Diagnosis, Treatment, and Prognosis of Frozen Shoulder: A Consensus Survey of Shoulder Specialists. Clin Orthop Surg. 2020 Mar;12(1):60-67. doi: 10.4055/cios.2020.12.1.60. Epub 2020 Feb 13.
PMID: 32117540RESULTRedler LH, Dennis ER. Treatment of Adhesive Capsulitis of the Shoulder. J Am Acad Orthop Surg. 2019 Jun 15;27(12):e544-e554. doi: 10.5435/JAAOS-D-17-00606.
PMID: 30632986RESULTCatapano M, Mittal N, Adamich J, Kumbhare D, Sangha H. Hydrodilatation With Corticosteroid for the Treatment of Adhesive Capsulitis: A Systematic Review. PM R. 2018 Jun;10(6):623-635. doi: 10.1016/j.pmrj.2017.10.013. Epub 2017 Nov 10.
PMID: 29129609RESULTOh JH, Oh CH, Choi JA, Kim SH, Kim JH, Yoon JP. Comparison of glenohumeral and subacromial steroid injection in primary frozen shoulder: a prospective, randomized short-term comparison study. J Shoulder Elbow Surg. 2011 Oct;20(7):1034-40. doi: 10.1016/j.jse.2011.04.029. Epub 2011 Aug 4.
PMID: 21816628RESULTKim DY, Lee SS, Nomkhondorj O, Cho MG, Lee JJ, Hwang JT, Hong MS. Comparison Between Anterior and Posterior Approaches for Ultrasound-Guided Glenohumeral Steroid Injection in Primary Adhesive Capsulitis: A Randomized Controlled Trial. J Clin Rheumatol. 2017 Jan;23(1):51-57. doi: 10.1097/RHU.0000000000000475. No abstract available.
PMID: 28002160RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jung Taek Hwang, MD, PhD
Chuncheon Sacred Heart Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- A final number of 50 patients were enrolled in the trial and randomly assigned to either the isolated corticosteroid injection group (Group CS) or the concomitant hydrodilatation group (Group CSHD). Double-blinded randomization was performed by an independent nurse using a computer-generated random sequence. A musculoskeletal radiologist, blinded to group allocation, performed the diagnostic ultrasound and MRI interpretations. A blinded orthopaedic nurse carried out the physical examination and clinical scoring.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 24, 2024
First Posted
July 10, 2024
Study Start
December 5, 2013
Primary Completion
November 17, 2015
Study Completion
November 17, 2015
Last Updated
July 10, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share